Titre:
  • Phase II study of E7070 in patients with metastatic melanoma.
Auteur:Smyth, J F; Aamdal, S; Awada, Ahmad; Dittrich, C; Caponigro, F; Schöffski, P; Gore, Martin; Lesimple, Thierry; Djurasinovic, N; Baron, Benoît; Ravic, M; Fumoleau, Pierre; Punt, Cornelis; EORTC New Drug Development and Melanoma Groups,
Informations sur la publication:Annals of oncology, 16, 1, page (158-161)
Statut de publication:Publié, 2005-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Disease Progression
Female
Humans
Infusions, Intravenous
Male
Melanoma -- drug therapy
Melanoma -- pathology
Middle Aged
Skin Neoplasms -- drug therapy
Skin Neoplasms -- pathology
Sulfonamides -- administration & dosage
Sulfonamides -- adverse effects
Sulfonamides -- therapeutic use
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdi016
info:pii/16/1/158
info:scp/19944427395
info:pmid/15598954